Week of March 14th 2022 | Vol. 11, Issue 11
Events Hosted or Attended by Bourne Partners
March 16-18, 2022 - Aventura, FL
March 21-24, 2022 - New York City, NY
May 17-19, 2022 - Philadelphia, PA
May 24-26, 2022 - New York City, NY
April 23-26, 2022 - Palm Beach, FL
June 13-16, 2022 - San Diego, CA
August 27-29, 2022 - Boston, MA
October 2022 - Charlotte, NC
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
Insight Into Healthcare Related Industries
Representative Current Retained Sell-Side And Partnering Opportunities
Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
A Sampling of Industry Headlines From Last Week
Since May 2020, Eli Lilly’s had a plot picked out in North Carolina’s famed Research Triangle Park. The area's pull proved so fierce that Lilly last year snapped up 102 acres more.
In Novartis’ perennial hunt for innovative therapies to bring under its wing, improving on gene therapy has always been kept top of mind.
Life science consulting firm Trinity Life Sciences is calling on the FDA to implement minimum representation requirements for clinical trials to help boost diversity in studies.
International Women's Day was Tuesday, and, at the ViVE 2022 conference this week, the impact of female founders and executives touched almost every conversation about the future of healthcare and tech.

The work of TannerGAP includes addressing medicine market withdrawal, post-clinical trial solutions, mitigating drug shortages and managing medicine supply on a Named Patient basis. Learn more from TannerGAP EVP, Maryori Alvarenga.

The Tanner team is continuously learning and seeking opportunities to enhance global access to new medicines and diagnostics. TannerLAC team members recently traveled to Germany to receive training on Epimune GmbH's i.Mune® tests, with future plans to bring the innovative product to Latin America. Learn more about the division’s first diagnostic product.

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.